01-Jul-2026 08:45:34

MOREPEN LABORATORIES : STARTS COMMERCIAL SUPPLIES UNDER RS 825 CR CDMO MANDATE

• First dispatch valued at ~₹50 Cr completed in Q1FY2026-27, marking transition to commercial stage • Company expects to scale program further with additional supplies of ~₹225 Cr in Q2FY2026-27 • Reactor capacity expected to reach ~600 KL by end of Q2, with further expansion to 800 KL and 1,000 KL planned • Strategy focuses on building a scalable CDMO platform, deepening customer partnerships

Morepen Laboratories Limited

← Back to feed